Jennifer Cook

Track

Insider profile

Currently holds positions in Denali Therapeutics Inc and BridgeBio Pharma Inc

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return -0% 8.2% 15.1%
Success rate 67% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Denali Therapeutics Inc Nov. 6, 2018 -
Independent Director BridgeBio Pharma Inc Dec. 1, 2019 -
Jennifer Cook's trades of BridgeBio Pharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
281.53
Quantity 89,183 -34.3%
Value US$2,829,143
Transaction date
Planned sale
Price
335.00
Quantity 21,816 -33.5%
Value US$2,728,387
Transaction date
Proposed sale
Price
366.73
Quantity 63,265
Value US$3,366,165
Transaction date
Planned sale
Price
70.00
Quantity 37,167 -81.6%
Value US$2,601,690
Transaction date
Proposed sale
Price
70.00
Quantity 37,167
Value US$2,601,690
Transaction date
Planned sale
Price
68.57
Quantity 2,196 -20.8%
Value US$150,580
Transaction date
Proposed sale
Price
68.57
Quantity 2,196
Value US$150,580
Transaction date
Planned sale
Price
67.14
Quantity 1,503 -18.6%
Value US$100,915
Transaction date
Planned sale
Price
66.62
Quantity 88,737 -91.6%
Value US$5,911,242
Transaction date
Proposed sale
Price
66.62
Quantity 90,240
Value US$6,012,159
Transaction date
Proposed sale
Price
112.00
Quantity 3,731
Value US$417,872
Transaction date
Proposed sale
Price
111.00
Quantity 3,075
Value US$341,325
Transaction date
Proposed sale
Price
21.85
Quantity 1,458
Value US$31,857
Transaction date
Proposed sale
Price
135.18
Quantity 2,561
Value US$346,196
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-13 2026-07-09
PlS Planned sale
89,183 -34.3%
281.53
US$2,829,143 		89,183 -34.3% 281.53 US$2,829,143
2026-07-13 2026-07-09
PlS Planned sale
21,816 -33.5%
335.00
US$2,728,387 		21,816 -33.5% 335.00 US$2,728,387
2026-07-09 2026-07-09
PrS Proposed sale
63,265
366.73
US$3,366,165 		63,265 366.73 US$3,366,165
2026-06-24 2026-06-24
PlS Planned sale
37,167 -81.6%
70.00
US$2,601,690 		37,167 -81.6% 70.00 US$2,601,690
2026-06-24 2026-06-24
PrS Proposed sale
37,167
70.00
US$2,601,690 		37,167 70.00 US$2,601,690
2026-06-24 2026-06-23
PlS Planned sale
2,196 -20.8%
68.57
US$150,580 		2,196 -20.8% 68.57 US$150,580
2026-06-23 2026-06-23
PrS Proposed sale
2,196
68.57
US$150,580 		2,196 68.57 US$150,580
2026-06-17 2026-06-15
PlS Planned sale
1,503 -18.6%
67.14
US$100,915 		1,503 -18.6% 67.14 US$100,915
2026-06-17 2026-06-15
PlS Planned sale
88,737 -91.6%
66.62
US$5,911,242 		88,737 -91.6% 66.62 US$5,911,242
2026-06-15 2026-06-15
PrS Proposed sale
90,240
66.62
US$6,012,159 		90,240 66.62 US$6,012,159
2025-08-08 2025-08-08
PrS Proposed sale
3,731
112.00
US$417,872 		3,731 112.00 US$417,872
2024-08-05 2024-08-06
PrS Proposed sale
3,075
111.00
US$341,325 		3,075 111.00 US$341,325
2024-06-10 2024-06-06
PlS Planned sale
1,458 -6.8%
21.73
US$31,682 		1,458 -6.8% 21.73 US$31,682
2024-06-06 2024-06-06
PrS Proposed sale
1,458
21.85
US$31,857 		1,458 21.85 US$31,857
2023-12-06 2023-12-04
S Sale
417 -5.7%
119.27
US$49,736 		417 -5.7% 119.27 US$49,736
2023-08-15 2023-08-14
S Sale
1,241 -14.5%
138.16
US$171,454 		1,241 -14.5% 138.16 US$171,454
2023-08-14 2023-08-14
PrS Proposed sale
2,561
135.18
US$346,196 		2,561 135.18 US$346,196
2022-12-06 2022-12-02
S Sale
420 -7.1%
154.68
US$64,966 		420 -7.1% 154.68 US$64,966
2022-08-09 2022-08-08
S Sale
1,089 -15.6%
152.32
US$165,879 		1,089 -15.6% 152.32 US$165,879
2021-12-06 2021-12-02
S Sale
417 -8.6%
121.30
US$50,582 		417 -8.6% 121.30 US$50,582